Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0001193125-26-002448

Chief Financial Officer sold 6,294 shares at $27.10 ($170,567)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Emany Sravan Kumar Chief Financial Officer 2025-12-31 Sale 10b5-1 −6,294 $27.10 $170,567 73,706 D: show line 1 in the form
Open-market sales · 6,294 sh · avg $27.10 · $170,567
Loading xslF345X05/ownership.xml…